New device zaps nerves to calm overactive bladder – early trial underway
NCT ID NCT05874375
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early study tests a device called UCon that sends mild electrical pulses through the skin to calm bladder nerves. Twenty men with overactive bladder will use the device at home for a few weeks. The goal is to see if it is safe and if it reduces urgency, leaks, and nighttime urination.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- UCon device (electrical nerve stimulation through the skin)
- What this could lead to
- If it works, this could offer a non-drug, non-surgical option for men with overactive bladder to reduce urgency, leaks, and nighttime bathroom trips.
- What could go wrong
- This is a very early, small study with only 20 men. The device may not work as hoped, and side effects or discomfort from stimulation are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 20 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2023
- Expected to finish
-
Jun 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Subject is ≥ 18 years of age. 2. Subject is male. 3. Subject is diagnosed with OAB 4. Subject is able to communicate, provide feedback, understand and follow instructions during the course of the investigation. Exclusion Criteria: 1. Subject is medically unstable (acute illness or complications of a chronic condition that might affect the subject's participation in the investigation). 2. Subject has a Post Void Residual (PVR) of more than 100 ml or a Bladder Voiding Efficiency (BVE) of less than 75% (measured by uroflowmetry as the ratio of voided volume (VV) and total bladder capacity (VV+PVR)). 3. Subject has an active infection in the genital area incl. skin infections and urinary tract infection. 4. Subject has had botulinum toxin (BOTOX) treatment in the pelvic region within 6 months. 5. Subject has used antimuscarinics or β3 agonists within 14 days weeks\*. 6. Subject has an implanted pacemaker, implantable drug pump or other active medical device (any medical device that uses electrical energy or other source of power to make it function). 7. Subject is enrolled or planning to enrol in another clinical investigation or was enrolled in an investigational drug study or medical device investigation within four weeks to enrolment. 8. Subject has neuropathy to a degree that is presumed to diminish the effect of the electrical stimulation. 9. Subject has a history of cancer in the pelvic region, are currently receiving cancer treatment, or has radiation-induced damage to the pelvic region. 10. Subject has addictive behaviour defined as abuse of alcohol, cannabis, opioids, or other intoxicating drugs. 11. Subject does not speak and understand Dutch. * If a subject is currently being treated with antimuscarinics or β3 agonists, he is allowed to be included in the investigation, however, a washout period of 14 days is required before baseline can be established.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Incontinence, nighttime urinary are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Maastricht University Medical Center+
RECRUITINGMaastricht, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Two bladder drugs face off over nighttime bathroom trips
- Estrogen drop may hold clue to bladder leaks in women with spinal cord injury
- Bladder leaks may signal frailty in older adults
- A gentler catheter may cut infection risk for women in hospitals
- Can a Full-Body rehab program help children stop wetting?
- Magnetic chair therapy aims to strengthen pelvic floor without surgery